Viewing Study NCT05296603


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-02-13 @ 10:13 AM
Study NCT ID: NCT05296603
Status: RECRUITING
Last Update Posted: 2024-01-10
First Post: 2022-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer
Sponsor: Hunan Province Tumor Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module